Newpharma

The company operates by selling non-prescription drugs and a wide array of parapharmaceutical products, including cosmetics, vitamins, and baby care items. Its business model is direct-to-consumer e-commerce, generating revenue by selling these products online. All orders are prepared and controlled by pharmacists from a physical public pharmacy in Liège, ensuring safety and compliance with regulations. Newpharma serves customers in several European countries, with Belgium and France being its primary markets. The platform offers a catalog of over 47,000 products from 1,700 brands and provides 24-hour delivery within Belgium.

In 2017, Colruyt Group and its family's investment firm, Korys, acquired a majority stake in Newpharma. By July 2021, Colruyt Group increased its ownership to 61%, and together with Korys, they now own 100% of the company. This acquisition is part of Colruyt Group's broader strategy to invest in health-related services and expand its e-commerce leadership. Following the acquisition, the company has continued to invest in automation and logistics, including the construction of a new distribution center in Liège to support its growth.